Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently raised its full-year guidance to reflect the strong performance of the pharmaceutical and medical
Johnson & Johnson
-(JNJ)
XNYS:JNJ
JNJ Earnings: All you need to know about Johnson & Johnson’s Q3 2023 earnings results
Johnson & Johnson (NYSE: JNJ) reported third quarter 2023 earnings results today. Reported sales increased 6.8% year-over-year to $21.3 billion. Operational sales
Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q3 2023 Earnings Call dated Oct. 17, 2023 Corporate Participants: Jessica Moore -- Vice President - Investor
Johnson & Johnson to report earnings on Oct 17. Here’s what to look for
After reporting better-than-expected quarterly earnings consistently for over a decade, healthcare behemoth Johnson & Johnson (NYSE: JNJ) is preparing to release its
Johnson & Johnson (JNJ) Q2 2023 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported second quarter 2023 earnings results today. Reported sales increased 6.3% year-over-year to $25.5 billion. GAAP net
Earnings Preview: Here’s what to expect from Johnson & Johnson’s Q2
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) entered a new phase recently after spinning off its consumer business. The move is part
Johnson & Johnson (JNJ) Q1 2023 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q1 2023 earnings call dated Apr. 18, 2023 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joseph J.
JNJ Earnings: All you need to know about Johnson & Johnson’s Q1 2023 earnings results
Johnson & Johnson (NYSE: JNJ) reported its first quarter 2023 earnings results today. Reported sales increased 5.6% year-over-year to $24.7 billion. On a
Johnson & Johnson (JNJ) Q4 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2022 earnings call dated Jan. 24, 2023 Corporate Participants: Jessica Moore -- Vice President of Investor Relations Joaquin
JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2022 earnings results
Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2022 earnings results today. Reported sales decreased 4.4% year-over-year to $23.7 billion. Net
JNJ Earnings: Johnson & Johnson Q3 adj. profit drops despite higher sales
Johnson & Johnson (NYSE: JNJ) reported a decline in adjusted profit for the third quarter of 2022, despite a modest increase in net
Johnson & Johnson (JNJ) offers long-term stability. Is the stock a buy?
Johnson & Johnson (NYSE: JNJ) has stayed largely unaffected by the COVID crisis and macroeconomic headwinds so far, which allowed the healthcare
Johnson & Johnson (JNJ) Q2 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joaquin Duato -- Chief
JNJ Earnings: Johnson & Johnson reports higher sales and adj. profit for Q2
Johnson & Johnson (NYSE: JNJ) reported an increase in sales and adjusted profit for the second quarter of 2022 when strong performance by
What awaits Johnson & Johnson (JNJ) beyond consumer business spinoff
Johnson & Johnson (NYSE: JNJ) is probably the most diversified healthcare firm that owns several popular consumer brands, which have brought both
Infographic: Highlights of Intuitive Surgical’s Q1 2022 earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a decline in first-quarter earnings despite a double-digit growth in revenues, hurt
Kimberly-Clark (KMB) Q1 profit drops but beats estimates; revenue up 7%
Consumer products company Kimberly-Clark Corp. (NYSE: KMB) reported stronger-than-expected earnings and revenues for the first quarter of 2022. The company's stock made
Johnson & Johnson (JNJ) Q1 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q1 2022 earnings call dated Apr. 19, 2022 Corporate Participants: Joseph J. Wolk -- Executive Vice President, Chief Financial
Johnson & Johnson (JNJ) reports Q1 2022 earnings
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2022 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Johnson & Johnson (JNJ) Q4 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2021 earnings call dated Jan. 25, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joseph J. Wolk -- Executive
Johnson & Johnson (JNJ) reports Q4 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue